文献速递药疹与重症皮肤不良反应

药物超敏反应综合征/DRESS:流行病学、发病机制、临床病理与预后

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
PubMed 文献 · J Am Acad Dermatol · 2023-07-27

本文为DiHS/DRESS继续医学教育第一部分,概述其以皮疹、发热及血液和内脏器官受累为特征的严重皮肤不良反应。抗惊厥药、抗生素和别嘌醇是最常见诱因,发病机制涉及药物、病毒与T细胞介导免疫的复杂相互作用。典型表现为用药后2-6周出现麻疹样皮疹,伴显著发病率、死亡率和复发风险,长期后遗症主要与器官功能障碍和自身免疫病相关。

要点

  • DiHS/DRESS典型表现为用药后2-6周出现麻疹样皮疹,伴发热及血液和内脏器官受累。
  • 抗惊厥药、抗生素和别嘌醇是最常见诱因。
  • 发病机制为药物、病毒与T细胞介导免疫的复杂相互作用,可致显著发病率、死亡率和复发风险。

核心结论

  • DiHS/DRESS是伴皮疹、发热及血液和内脏器官受累的严重皮肤不良反应,与显著发病率、死亡率及复发风险相关。
  • 长期后遗症主要涉及器官功能障碍和自身免疫病。

研究设计与样本

  • 本文为DiHS/DRESS继续医学教育第一部分,提供流行病学更新、发病机制新见解及临床病理特征和预后描述。

主要发现

  • 抗惊厥药、抗生素和别嘌醇是最常见诱因。
  • 发病机制涉及药物、病毒与免疫系统间主要由T细胞介导的复杂相互作用。
  • DiHS/DRESS通常在用药后2-6周出现麻疹样皮疹。
  • 该病与显著发病率、死亡率和复发风险相关。
  • 长期后遗症主要与器官功能障碍和自身免疫病相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction (SCAR) characterized by an exanthem, fever, and hematologic and visceral organ involvement. Anticonvulsants, antibiotics, and allopurinol are the most common triggers. The pathogenesis involves a complex interplay between drugs, viruses, and the immune system primarily mediated by T-cells. DiHS/DRESS typically presents with a morbilliform eruption 2-6 weeks after drug exposure, and is associated with significant morbidity, mortality, and risk of relapse. Long-term sequelae primarily relate to organ dysfunction and autoimmune diseases. Part I of this continuing medical education activity on DiHS/DRESS provides an update on epidemiology, novel insights into pathogenesis, and a description of clinicopathological features and prognosis.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Wei BM, Fox LP, Kaffenberger BH, et al. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. J Am Acad Dermatol. 2023. PMID: 37516359. doi:10.1016/j.jaad.2023.02.072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。